Guest Essay: Protecting your skin this spring break Highland Park News Thu, 01 Apr 2010 02:00 AM PDT April is here and spring break is just around the corner for most students across the country. Many are anxious to escape the cold weather and shed some layers of clothing. The Skin Cancer Foundation would like to remind students to protect themselves during their time in the sun. New research shows that it's very important for students to be extra vigilant while on spring break. | Europe debates cancer screening The Monterey County Herald Thu, 01 Apr 2010 01:59 AM PDT BARCELONA, Spain â" Are doctors over-treating breast cancer? At a recent breast cancer conference in Barcelona, experts discussed how to implement mammogram screening programs across Europe, balancing fighting cancer with the goal of targeting only those women who need to be screened. | (AFX UK Focus) 2010-04-01 09:29 UPDATE 2-Sanofi settles with Sandoz, Teva on Eloxatin patent Interactive Investor Thu, 01 Apr 2010 01:57 AM PDT PARIS, April 1 (Reuters) - French drugmaker Sanofi-Aventis has settled a patent law suit over cancer drug Eloxatin, putting a block on several other drugmakers selling their generic versions from late June until August 2012. The agreement, announced on Thursday, partially resolved litigation with Teva Pharmaceuticals, Fresenius Kabi and Novartis' Sandoz unit after they launched a cheaper copy ... | Pacific Grove High senior organizes bone marrow drive The Monterey County Herald Thu, 01 Apr 2010 01:52 AM PDT Eight million aren't enough. That's the number of potential bone marrow donors enrolled by Be The Match, a national organization dedicated to fighting leukemia. The organization is building lists of potential donors for those who need bone marrow or blood cell transplants to fight blood cancer. | US judge rules cancer gene patent invalid, Myriad Genetics to appeal PharmaBiz Thu, 01 Apr 2010 01:43 AM PDT Myriad Genetics, Inc. announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis are invalid. | (AFX UK Focus) 2010-04-01 09:24 Orion CEO sees no sales impact from FDA drug probe Interactive Investor Thu, 01 Apr 2010 01:43 AM PDT HELSINKI, April 1 (Reuters) - Finnish drugs maker Orion said it does not expect sales to be hit by news the U.S. Food and Drug Administration is evaluating clinical data that may suggest its Parkinson's drug Stalevo is tied to an increased risk of prostate cancer. "This is no such thing that we would see a sales impact ... We have not seen this is as such a significant matter that we would need ... | Lives altered by mass shooting a year ago in NY Kerrville Daily Times Thu, 01 Apr 2010 01:43 AM PDT BINGHAMTON, N.Y. (AP) -- Layla Khalil survived breast cancer, a bus hijacking and a suicide bombing in Iraq. Yet even in the chaos of war, the mother of three never tired of reciting her magic recipe for a fulfilling life: "Just focus on your studies!" | | |
|
No comments:
Post a Comment